Fungal Chitosan Derivatives

Fungal Chitosan Derivatives

More about our innovation
Technologies

From Fungal Chitosan to precision-engineered derivatives.

Technology - Fungal chitosan derivatives

Developed through controlled functionalization of KitOzyme's fungal chitosan platform, to address specific market needs and unlock new formulation performance.

OUR FOUNDING INNOVATION

Pioneering non-animal chitosan from fungal biomass

KitOzyme's fungal chitosan derivatives are purpose-built variations of its fungal chitosan platform, produced through controlled chemical modifications that deliver targeted properties native chitosan alone cannot achieve.

How does it address your specific application needs?

Each modification is designed to unlock a specific performance profile: optimized film formation, enhanced cationic charge, complex coacervation, or controlled release, while preserving the non-animal origin and clean regulatory profile of the base material.

What do they all share?

– Non-animal origin
– Non-GMO
– Allergen-free
– Manufactured in Belgium
– Full traceability and batch-to-batch consistency

What sets it apart from conventional chitosan derivatives?

This is not a catalogue of off-the-shelf modifications. It is a dynamic innovation platform, open to co-development and capable of designing new derivative building blocks adapted to emerging customer needs.

– Non-animal chitosan derivatives with targeted functionality
– Cleaner and more differentiated formulations
– Compatibility with vegan, halal, and kosher positioning

OUR SCIENCE
KitOderm fungal chitosan for skin care

How does this translate into formulation performance?

The functionality of mushroom chitosan derivatives is tuned by controlling key molecular parameters: molecular weight (MW), degree of deacetylation (DD), charge density, solubility, viscosity and chemical functionalization.

  • Optimized film-forming properties.
  • Enhanced cationic charge and electrostatic interactions.
  • Modified solubility and processing behaviour.
  • Complex coacervation and encapsulation capabilities.
  • Controlled release functionalities.
  • Broader co-formulation opportunities with complementary biopolymers.

The cationic nature of these derivatives enables interactions with anionic biopolymers, proteins, and active compounds and opens formulation opportunities not achievable with neutral polysaccharides.

Fungal chitosan derivatives are not isolated ingredients. They are part of a broader technology platform built on functional molecular design.

The KitOzyme difference
KitOzyme fungal chitosan news

What does that mean for your project?

Built on the same fungal chitosan foundation, KitOzyme’s derivatives are engineered for specific performance profiles and application requirements that call for a more targeted approach.

  • Support for encapsulation
  • Complex coacervation
  • Interfacial systems
  • Controlled-release applications

This unique and patented technology platform gives formulators access to clear advantages for product development and a co-development pathway for tailored solutions.

And a regulatory track record to match.

All derivatives share the same core strengths as the base platform: non-animal origin, full traceability, and Belgian manufacturing under controlled industrial processes.

Together, these elements make KitOzyme’s fungal chitosan derivatives more than formulation ingredients. They form part of a unique technology platform that delivers cleaner, more precise, and higher-performing solutions across multiple markets.

Domains

Our solutions

KitOzyme has built a portfolio of fungal chitosan derivative-based solutions serving multiple industries.

What applications does it serve today?

Beyond existing grades, KitOzyme's R&D team designs new derivative building blocks adapted to emerging customer needs, from modified solubility profiles to advanced encapsulation systems.

Open to co-development, KitOzyme works closely with partners to identify, design, and develop the most relevant solutions for their projects.

Frequently asked questions

Find clear, science-backed answers to common questions about our fungal biopolymers, applications, regulatory compliance, and formulation integration.

All questions
  • Yes. All KitOzyme fungal chitosan derivatives share the same non-animal, non-GMO, and allergen-free profile as the base platform. They are manufactured in Belgium under controlled industrial processes and are compatible with vegan, halal, and kosher formulation requirements. 

  • Yes. KitOzyme’s R&D team works closely with partners to identify, design, and develop tailored fungal chitosan derivative solutions. Beyond existing grades, new derivative building blocks can be designed to address emerging customer needs, from modified solubility profiles to advanced encapsulation or controlled-release systems. Contact our team to discuss your co-development project. 

  • Fungal chitosan is KitOzyme’s core biopolymer, a versatile, non-animal cationic polysaccharide with a broad spectrum of functional properties. Fungal chitosan derivatives are purpose-built variations of this base material, developed through controlled chemical functionalization to deliver targeted performance profiles that includes optimized film formation, enhanced charge density, complex coacervation capacity, or controlled release functionality for specific applications and market requirements.